API SHARES SURGE ON SIGMA SPECULATION

Pharmaceuticals maker and distributor Sigma Pharmaceuticals Ltd will most likely have to offer more than $2.20 per share if it is to secure rival Australian Pharmaceutical Industries Ltd (API), according to an analyst. The Sydney Morning Herald (http://www.smh.com.au/news/Business/API-shares-surge-on-Sigma-speculation/2006/10/09/1160246065908.html)